Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Minerva Neurosciences, Inc (NERV)

« Back to company index

NERV Chatter Timeline

Stock Ticker for NERV

Most Active Tweeters for NERV

UserTweets
@Tickeron 12
@gcassidy718 6
@tradersreport 2
@76enz 2
@dailypoliticaln 2

Recent Tweets for NERV

semodough @semodough
HCW - last week KOLs Highlight Roluperidone as Potential Game Changer; Reiterate Buy- excellent read on $NERV… https://t.co/zqOICkMiyH
April 4th 2020, 9:04pm
HealthcareBeat @HealthcareBeat
Minerva Neurosciences Inc Expected to Post Earnings of -$0.37 Per Share $NERV https://t.co/uxUo4fJ2a3
April 4th 2020, 6:04pm
gcassidy718 @gcassidy718
$NERV headed twds $4.78 . EOQ -6.68 % change recently https://t.co/0qOVKeUGMi
April 4th 2020, 5:04pm
stocknewstimes @stocknewstimes
Minerva Neurosciences Inc $NERV Expected to Post Earnings of -$0.37 Per Share https://t.co/bAknhRtNIL
April 4th 2020, 9:04am
TranscriptDaily @TranscriptDaily
Minerva Neurosciences Inc $NERV Expected to Post Earnings of -$0.37 Per Share https://t.co/PomGwMVuFG
April 4th 2020, 9:04am
dispatchtribune @dispatchtribune
Minerva Neurosciences Inc $NERV Expected to Post Earnings of -$0.37 Per Share https://t.co/H3czOOU8H0
April 4th 2020, 9:04am
ConsumerFeed @ConsumerFeed
Minerva Neurosciences Inc $NERV Expected to Post Earnings of -$0.37 Per Share https://t.co/xvIbWu3uWt
April 4th 2020, 9:04am
Tickeron @Tickeron
$NERV's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for… https://t.co/ONtnjue7sx
April 4th 2020, 1:04am
fda_tracker @fda_tracker
$NERV Phase 3 trial w/est Apr completion date NCT03397134: https://t.co/sC7hmLWKf5 Trial Tracker: https://t.co/aR7q5oJwjn
April 3rd 2020, 9:04am
Tickeron @Tickeron
$NERV's Aroon indicator reaches into Uptrend on March 27, 2020. View odds for this and other indicators:… https://t.co/MVA5IMh3ez
April 3rd 2020, 2:04am
RolandoAMoreno @RolandoAMoreno
RT @semodough: $NERV MGT does not think Covid-19 should affect the expected readout of the roluperidone Phase 3 trial slated for 2Q20. The…
April 2nd 2020, 12:04pm
semodough @semodough
$NERV MGT does not think Covid-19 should affect the expected readout of the roluperidone Phase 3 trial slated for 2… https://t.co/crtkFfIlWj
April 2nd 2020, 8:04am
TheMarketsDaily @TheMarketsDaily
Minerva Neurosciences $NERV Upgraded at ValuEngine https://t.co/6VFkEz3Iy2
April 2nd 2020, 6:04am
dailypoliticaln @dailypoliticaln
Minerva Neurosciences $NERV Upgraded at ValuEngine https://t.co/Iviswqj2Ah
April 2nd 2020, 6:04am
gcassidy718 @gcassidy718
$NERV Holding this one for the long haul. -2.50 % https://t.co/0qOVKeUGMi
April 2nd 2020, 12:04am
fintel_io @fintel_io
$NERV / Minerva Neurosciences files form 8-K - Regulation FD Disclosure, Financial Statements and Exhibits https://t.co/UOFYyfP30y
April 1st 2020, 4:04pm
Stock_News_Now @Stock_News_Now
$NERV: New SEC Filing for NERV: Form 8-K (No. 0001193125-20-094671): https://t.co/KTGCSw88Kq
April 1st 2020, 4:04pm
odibro @odibro
$NERV Slides https://t.co/okrY02k40J
April 1st 2020, 4:04pm
ThisLincolnian @ThisLincolnian
Minerva Neurosciences Inc $NERV Expected to Announce Earnings of -$0.37 Per Share https://t.co/CC6W97Jvx1
April 1st 2020, 5:04am
AmericanBanking @AmericanBanking
Minerva Neurosciences Inc $NERV Expected to Announce Earnings of -$0.37 Per Share https://t.co/sdgRmftWs7 #stocks
April 1st 2020, 5:04am
TickerReport @TickerReport
-$0.37 EPS Expected for Minerva Neurosciences Inc $NERV This Quarter https://t.co/5HWF5PgIs9
April 1st 2020, 5:04am
EnterpriseLeade @EnterpriseLeade
Minerva Neurosciences Inc $NERV Expected to Announce Earnings of -$0.37 Per Share https://t.co/f2RzA7DEMg
April 1st 2020, 5:04am
WatchlistN @WatchlistN
Minerva Neurosciences Inc $NERV Expected to Announce Earnings of -$0.37 Per Share https://t.co/o98BR7jyNI
April 1st 2020, 5:04am
tradersreport @tradersreport
RT @Tickeron: $NERV's Aroon indicator reaches into Uptrend on March 27, 2020. View odds for this and other indicators: https://t.co/4p19my8…
April 1st 2020, 2:04am
Tickeron @Tickeron
$NERV's Aroon indicator reaches into Uptrend on March 27, 2020. View odds for this and other indicators:… https://t.co/zrufxT8Ddh
April 1st 2020, 2:04am
Tickeron @Tickeron
$NERV's price moved below its 50-day Moving Average on March 9, 2020. View odds for this and other indicators:… https://t.co/vGeEuX315m
March 31st 2020, 1:03am
gcassidy718 @gcassidy718
$NERV price movement 2.72 % https://t.co/0qOVKeUGMi
March 30th 2020, 10:03pm
gcassidy718 @gcassidy718
$NERV Major changes in stock price 3.48 % change recently https://t.co/0qOVKeUGMi
March 30th 2020, 1:03am
Tickeron @Tickeron
$NERV's price moved below its 50-day Moving Average on March 9, 2020. View odds for this and other indicators:… https://t.co/CCYcCSGaKZ
March 30th 2020, 1:03am
gcassidy718 @gcassidy718
$NERV Would say I'm surprised, but I'm not. Will check ER. Might dabble again. Maybe. 3.48 % change recently https://t.co/0qOVKeUGMi
March 29th 2020, 3:03am
Tickeron @Tickeron
$NERV's price moved below its 50-day Moving Average on March 9, 2020. View odds for this and other indicators:… https://t.co/MqG85rHNt4
March 29th 2020, 1:03am
gcassidy718 @gcassidy718
$NERV I am gona keep buying until it hits $6.17 dollars -7.12 % change https://t.co/0qOVKeUGMi
March 28th 2020, 6:03am
Tickeron @Tickeron
$NERV's price moved below its 50-day Moving Average on March 9, 2020. View odds for this and other indicators:… https://t.co/JRXsVVC2Uo
March 28th 2020, 3:03am
Tickeron @Tickeron
$NERV's price moved below its 50-day Moving Average on March 9, 2020. View odds for this and other indicators:… https://t.co/8uTp0KabSy
March 27th 2020, 2:03am
76enz @76enz
$NERV https://t.co/ZsRcvc0XTq
March 26th 2020, 11:03am
76enz @76enz
$NERV 10%
March 26th 2020, 11:03am
Tickeron @Tickeron
$NERV's price moved below its 50-day Moving Average on March 9, 2020. View odds for this and other indicators:… https://t.co/6PiVdM48HD
March 26th 2020, 1:03am
Tickeron @Tickeron
$NERV's price moved below its 50-day Moving Average on March 9, 2020. View odds for this and other indicators:… https://t.co/oX7UkA2h1p
March 25th 2020, 5:03am
StockNewsNow @StockNewsNow
$NERV MINERVA NEUROSCIENCES TO HOST KEY OPINION LEADER MEETING ON ROLUPERIDONE: A POTENTIALLY NOVEL MECHANISM TO TR… https://t.co/PC8yIyIZJu
March 24th 2020, 6:03pm
otcdynamics @otcdynamics
$NERV MINERVA NEUROSCIENCES TO HOST KEY OPINION LEADER MEETING ON ROLUPERIDONE: A POTENTIALLY NOVEL MECHANISM TO https://t.co/JP4nHSwXbQ
March 24th 2020, 12:03pm
ZolmaxNews @ZolmaxNews
Minerva Neurosciences $NERV Trading 6.3% Higher https://t.co/dLtZHp5hFm
March 24th 2020, 11:03am
WatchlistN @WatchlistN
Minerva Neurosciences $NERV Trading 6.3% Higher https://t.co/T7WhUzgkQP
March 24th 2020, 11:03am
dispatchtribune @dispatchtribune
Minerva Neurosciences $NERV Trading 6.3% Higher https://t.co/6JHzWjSyI8
March 24th 2020, 11:03am
dailypoliticaln @dailypoliticaln
Minerva Neurosciences $NERV Shares Up 6.3% https://t.co/scywiEnQLc
March 24th 2020, 11:03am
tradersreport @tradersreport
RT @Tickeron: $NERV's price moved below its 50-day Moving Average on March 9, 2020. View odds for this and other indicators: https://t.co/q…
March 23rd 2020, 3:03am
Tickeron @Tickeron
$NERV's price moved below its 50-day Moving Average on March 9, 2020. View odds for this and other indicators:… https://t.co/0h7J7xuK4G
March 23rd 2020, 3:03am
Tickeron @Tickeron
$NERV's price moved below its 50-day Moving Average on March 9, 2020. View odds for this and other indicators:… https://t.co/vY597Mmhfu
March 22nd 2020, 1:03am
BlueBioNow @BlueBioNow
$NERV significant price movement on this stock 4.94 % change recently https://t.co/NoVetki1TG
March 21st 2020, 11:03pm
WeekHerald @WeekHerald
Brokerages Set Minerva Neurosciences Inc $NERV PT at $19.00 https://t.co/VupOLRiknm
March 21st 2020, 11:03am
Tickeron @Tickeron
$NERV's price moved below its 50-day Moving Average on March 9, 2020. View odds for this and other indicators:… https://t.co/oxTGs82DMm
March 21st 2020, 2:03am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.